SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sugen (SUGN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
550 25 0 SUGN
Emcee:  Phillipa Type:  Unmoderated
Does anyone follow Sugen? Any opinions? I know they have started phase II trials of SU101 (a cancer drug) which supposedly shows great promise (with wide range of possible uses). Also, they just signed an agreement with ArQule but the stock just sits.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
550finance.yahoo.com (snip) Press Release Source: Pfizer Inc. On Thursday March 1scaram(o)uche-3/11/2010
549Sutent Significantly Increases Progression Free Survival for Patients with Advanscaram(o)uche-3/12/2009
548See comment no.7 - pipeline.corante.comnigel bates-6/2/2006
547Fun! Thanks for thinking to post it for us. Rickscaram(o)uche-8/4/2005
546Cool! One more time around. Might just bear watching. <i>NeoRx Joins Thkeokalani'nui-8/4/2005
545Message 21549158scaram(o)uche-7/28/2005
544Pfizer's Sutent doubles survival in GI cancer-study Sat May 14, 2005 05:34 Pscaram(o)uche-5/14/2005
543Message 21244908scaram(o)uche-4/20/2005
542<i>From The Scientist the-scientist.com </i> Volume 19 | Issue 7 | tnsaf-4/13/2005
541Pfizer stomach-cancer drug succeeds in trial Tue Feb 8, 2005 09:16 AM ET NEW YOscaram(o)uche-2/8/2005
540Nice. (eom)nigel bates-2/2/2005
539very, very cool.......... Pfizer Stops Cancer Drug Test Early Due To Effectivenscaram(o)uche-2/2/2005
538Message 20479913scaram(o)uche-9/2/2004
537Message 20200582scaram(o)uche-6/7/2004
536Pfizer cancer drug shows promise in early trial Sunday June 6, 11:04 am ET NEWscaram(o)uche-6/6/2004
535New cancer drugs aim at multiple targets Friday June 4, 3:49 pm ET By Toni Clarscaram(o)uche-6/5/2004
534Thanks, nice to have that lead! (eom)scaram(o)uche-12/9/2002
53312/6/2002 -- A California research team has mapped an entire group of human enzynigel bates-12/9/2002
532just posting to keep the thread open (eom)scaram(o)uche-11/20/2002
531from a pointer, today's BioCentury article "Pharmacogenetics might havescaram(o)uche-2/26/2002
530SU6668 was the molecule that held my interest. I haven't tried to follow itscaram(o)uche-2/10/2002
529Pharmacia Announces Closing of SU5416 (semaxanib) Clinical Trials PEAPACK, N.J.,tnsaf-2/10/2002
528Thursday October 25, 9:37 am Eastern Time Genentech cancer drug reaches clinicascaram(o)uche-10/25/2001
527J Biol Chem 2000 Sep 1;275(35):26690-5 The interaction oscaram(o)uche-10/15/2000
526Pharmacia Presents New Data on Cancer Drugs Showing Promise in Controlling and Sscaram(o)uche-10/13/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):